Big pharma threatens to file a lawsuit against a scientist exposing the safety of hydroxyethyl starch (HES)

The company, Fresenius Kabi, is threatening to lodge a compensation claim worth millions after Professor Anders Perner published a study arguing that a common treatment for severe sepsis with the drug hydroxyethyl starch (HES) can induce kidney failure and haemorrhages, which in the worst case can kill the patient.

Earlier this month, ScienceNordic reported on this study, which was published in The New England Journal of Medicine.

Click to expand...